Grace Therapeutics annual operating margin
2021
Grace Therapeutics's operating margin was −8,377.04% for fiscal 2021.
View full Grace Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-03-31 | −8,377.04% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2021 | 2020-12-31 | −2,424.69% | — |
The latest reported quarter, Q3 2021, shows −2,424.69%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Grace Therapeutics source filings ↗